首页> 外文期刊>Korean Circulation Journal >The Control of Drug Release and Vascular Endothelialization after Hyaluronic Acid-Coated Paclitaxel Multi-Layer Coating Stent Implantation in Porcine Coronary Restenosis Model
【24h】

The Control of Drug Release and Vascular Endothelialization after Hyaluronic Acid-Coated Paclitaxel Multi-Layer Coating Stent Implantation in Porcine Coronary Restenosis Model

机译:猪冠状动脉再狭窄模型中透明质酸涂层紫杉醇多层涂层支架植入后药物释放和血管内皮的控制。

获取原文
           

摘要

Background and Objectives Hyaluronic acid (HA) is highly biocompatible with cells and the extracellular matrix. In contrast to degradation products of a synthetic polymer, degradation products of HA do not acidify the local environment. The aim of this study was to fabricate an HA-coated paclitaxel (PTX)-eluting stent via simple ionic interactions and to evaluate its effects in vitro and in vivo. Materials and Methods HA and catechol were conjugated by means of an activation agent, and then the stent was immersed in this solution (resulting in a HA-coated stent). After that, PTX was immobilized on the HA-coated stent (resulting in a hyaluronic acid-coated paclitaxel-eluting stent [H-PTX stent]). Study groups were divided into 4 groups: bare metal stent (BMS), HA, H-PTX, and poly (L-lactide)-coated paclitaxel-eluting stent (P-PTX). Stents were randomly implanted in a porcine coronary artery. After 4 weeks, vessels surrounding the stents were isolated and subjected to various analyses. Results Smoothness of the surface was maintained after expansion of the stent. In contrast to a previous study on a PTX-eluting stent, in this study, the PTX was effectively released up to 14 days (a half amount of PTX in 4 days). The proliferation of smooth muscle cells was successfully inhibited (by 80.5±12.11% at 7 days of culture as compared to the control) by PTX released from the stent. Animal experiments showed that the H-PTX stent does not induce an obvious inflammatory response. Nevertheless, restenosis was clearly decreased in the H-PTX stent group (9.8±3.25%) compared to the bare-metal stent group (29.7±8.11%). Conclusion A stent was stably coated with PTX via simple ionic interactions with HA. Restenosis was decreased in the H-PTX group. These results suggest that HA, a natural polymer, is suitable for fabrication of drug-eluting stents (without inflammation) as an alternative to a synthetic polymer.
机译:背景与目的透明质酸(HA)与细胞和细胞外基质高度生物相容。与合成聚合物的降解产物相反,HA的降解产物不会酸化本地环境。这项研究的目的是通过简单的离子相互作用制造HA涂层的紫杉醇(PTX)洗脱支架,并评估其在体内和体外的作用。材料和方法HA和邻苯二酚通过活化剂结合,然后将支架浸入该溶液中(得到HA涂层支架)。之后,将PTX固定在HA涂层支架上(产生透明质酸涂层紫杉醇洗脱支架[H-PTX支架])。研究组分为4组:裸金属支架(BMS),HA,H-PTX和聚(L-丙交酯)涂层紫杉醇洗脱支架(P-PTX)。将支架随机植入猪冠状动脉。 4周后,分离支架周围的血管并进行各种分析。结果支架扩张后表面保持光滑。与先前对PTX洗脱支架的研究相比,在这项研究中,PTX的有效释放长达14天(4天的一半是PTX)。从支架释放的PTX成功地抑制了平滑肌细胞的增殖(在培养7天时,与对照相比,抑制了80.5±12.11%)。动物实验表明,H-PTX支架不会引起明显的炎症反应。尽管如此,与裸金属支架组(29.7±8.11%)相比,H-PTX支架组的再狭窄明显减少(9.8±3.25%)。结论通过与HA的简单离子相互作用,PTX可以稳定地覆盖支架。 H-PTX组再狭窄减少。这些结果表明,HA,一种天然聚合物,适合制造药物洗脱支架(无炎症),以替代合成聚合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号